Skip to main content
. 2016 May 18;49(1):129–140. doi: 10.4143/crt.2015.466

Fig. 3.

Fig. 3.

Kaplan-Meier curves for overall survival after bevacizumab failure are shown in late discontinuation (LD) and early discontinuation (ED) groups according to post-bevacizumab treatment. Patients who received salvage therapy showed significantly longer survival times in both groups. p-values were determined by log-rank tests.